Elections Reshape FDA Oversight Scene On Capitol Hill
This article was originally published in The Tan Sheet
The Republican takeover in the House shuffles the leadership in committees crucial to the dietary supplement and OTC drug industries while likely setting the stage for cuts to FDA funding.
You may also be interested in...
Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.
A congressional investigation into FDA's Puerto Rico district office is an early sign of the scrutiny awaiting the agency under a Republican-dominated House.
Rep. Joe Barton pushes to regain the Energy and Commerce Committee chair against the long odds of fellow Republicans appointing him to the post that wields significant influence over FDA and the OTC drug and nutritional product industries.